In contrast, Toll-like receptor 4 demonstrated significantly lower diagnostic performance in the differentiation of HCC versus HCV groups, showing %85 sensitivity and 85 % specificity (AUC:0.885, p < 0.00) (Table 4, Fig. 2). This evidence concerns the gene TLR4 and hepatocellular carcinoma.